Login
Toggle navigation
Videos
Categories
Trending
From combating food waste to pioneering projects|Archie Thomason,Associate,Milltrust International LLP
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
investor passionate about AgTech and the future of food production.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Addressing Structural Racism in Healthcare through Innovative Technology Solutions | Andrew Toy, CEO, Clover Health Investments Corp.
00:10:00
AdvTech Reports Strong Financial Performance with 22% Revenue Growth and Dividend Declaration | Roy Douglas, CEO, Advtech Ltd .
00:10:00
Interview with Luke Knight, CEO of Central Copper Resources
00:10:00
AGCO Chairman, President, and CEO Eric Hansotia discusses the company's strategic direction and future outlook.|Eric P. Hansotia is Chairman, President, CEO & COO at AGCO Corp
00:10:00
Exploiting Vanadium Opportunities in Scandinavia: Pursuit Minerals' Advanced Projects
00:10:00
"Unlocking Real Assets for Retail Investors: Insights from Dale Holmes of Spire Capital | Dale Holmes - Investment Strategist, Spire Capital"
00:10:00
The Bargainer: Shelby Steele on Race and American Identity|Shelby Steele
00:00:00
Cynata completes strategic review of development portfolio - Dr Kilian Kelly Chief Executive Officer and Managing Director, Cynata Therapeutics Ltd
00:10:00
Interview with Kevin Andrew Tan, CEO of Alliance Global Group Inc., conducted during the National Higher Education Day Summit 2024 by RTVMalacanang on January 16, 2023.|Kevin Andrew L.Tan currently works at Alliance Global Group, Inc., as Vice Chairman &
00:10:00
Tech Salary Report Insights with Art Zeile, CEO of DHI Group | Art Zeile - CEO of DHI Group, Inc.
00:10:00
Butterfield Investments: Generational Expertise and Company Retirement Plans
00:10:00
Fund Performance Review - December 2022 | Danilo Bredda - Member of the investment team at Alaska Investimentos,